Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

Sara Tambone; Maria C. Fargnoli; Rodolfo Capizzi; Ketty Peris

doi:10.23736/S0392-0488.17.05043-X

Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

Sara Tambone
, Maria C. Fargnoli
, Rodolfo Capizzi
, Ketty Peris

University of L'Aquila

Risultato della ricerca: Contributo in rivista › Articolo

4 Citazioni (Scopus)

Abstract

In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

Lingua originale	Inglese
pagine (da-a)	333-337
Rivista	Giornale Italiano di Dermatologia e Venereologia
Volume	153
DOI	https://doi.org/10.23736/S0392-0488.17.05043-X
Stato di pubblicazione	Pubblicato - 2018

Keywords

actinic keratosis
imiquimod

Accesso al documento

10.23736/S0392-0488.17.05043-X

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{072e7f3b2cd74894add2ebaeb3e18ad7,

title = "Clinical experience of imiquimod 3.75\% for actinic keratosis: results from a case series",

abstract = "In clinical studies, imiquimod 3.75\% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75\% in a real-life clinical setting.",

keywords = "actinic keratosis, imiquimod, actinic keratosis, imiquimod",

author = "Sara Tambone and Fargnoli, \{Maria C.\} and Rodolfo Capizzi and Ketty Peris",

year = "2018",

doi = "10.23736/S0392-0488.17.05043-X",

language = "English",

volume = "153",

pages = "333--337",

journal = "Giornale Italiano di Dermatologia e Venereologia",

issn = "0392-0488",

publisher = "Edizioni Minerva Medica S.p.A.",

}

TY - JOUR

T1 - Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

AU - Tambone, Sara

AU - Fargnoli, Maria C.

AU - Capizzi, Rodolfo

AU - Peris, Ketty

PY - 2018

Y1 - 2018

N2 - In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

AB - In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

KW - actinic keratosis

KW - imiquimod

KW - actinic keratosis

KW - imiquimod

UR - http://hdl.handle.net/10807/70478

U2 - 10.23736/S0392-0488.17.05043-X

DO - 10.23736/S0392-0488.17.05043-X

M3 - Article

SN - 0392-0488

VL - 153

SP - 333

EP - 337

JO - Giornale Italiano di Dermatologia e Venereologia

JF - Giornale Italiano di Dermatologia e Venereologia

ER -

Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo